Clinical trial
Ganglion Impar Neurolysis for Radiation-Induced Pain During Anal Cancer Treatment
NCT07112690 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ganglion Impar Neurolysis for Radiation-Induced Pain During Anal Cancer Treatment
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 10, 2025
- Completion date
- September 30, 2027
- Enrollment
- 5 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
localized anal carcinoma, localized anal margin carcinoma, stage 0 anal cancer ajcc v8, stage i anal cancer ajcc v8, stage ii anal cancer ajcc v8, stage iiib anal cancer ajcc v8